Home › Funds › Ramiah Investment Group › REGN

Ramiah Investment Group position in REGN

REGENERON PHARMACEUTICALS · Health Care

Ramiah Investment Group reported holding 534 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$405K, representing 0.31% of its reported portfolio and ranking #46 among its reported holdings. Ramiah Investment Group has disclosed REGN holdings in 6 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)534 sh
Reported value held$404.92K
Portfolio Weight0.31%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ramiah Investment Group's REGN position evolved

Ramiah Investment Group first disclosed a stake in REGN in Q2 2024 at 788 shares (US$828K). Across 6 filings, Ramiah Investment Group increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 534 shares valued at US$405K — a reduction of -24 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2024 (shares fell 32% over the following quarter), a 37% increase in Q1 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 788 $828.21K New
Q3 2024 467 $490.93K Reduce
Q4 2024 484 $344.77K Add
Q1 2025 663 $420.49K Add
Q2 2026 558 $347.94K New
Q3 2026 534 $404.92K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Ramiah Investment Group held REGN?

Ramiah Investment Group has disclosed REGN holdings in 6 of the last 10 reported quarters, going back to Q2 2024.

What is Ramiah Investment Group's current position in REGN?

As of Q3 2026, Ramiah Investment Group holds 534 shares of REGN (REGENERON PHARMACEUTICALS), valued at $404.92K, representing 0.31% of its reported portfolio and ranking #46.

Has Ramiah Investment Group been buying or selling REGN?

In the latest 13F filing (Q3 2026), Ramiah Investment Group reduced its position in REGN.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.